MY184269A - Broad-spectrum anti-influenza virus therapeutic peptides - Google Patents

Broad-spectrum anti-influenza virus therapeutic peptides

Info

Publication number
MY184269A
MY184269A MYPI2015002751A MYPI2015002751A MY184269A MY 184269 A MY184269 A MY 184269A MY PI2015002751 A MYPI2015002751 A MY PI2015002751A MY PI2015002751 A MYPI2015002751 A MY PI2015002751A MY 184269 A MY184269 A MY 184269A
Authority
MY
Malaysia
Prior art keywords
influenza virus
broad
therapeutic peptides
influenza
spectrum anti
Prior art date
Application number
MYPI2015002751A
Other languages
English (en)
Inventor
rajik Mohamed Ibrahim Mohamed
Original Assignee
Viramatix Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viramatix Sdn Bhd filed Critical Viramatix Sdn Bhd
Priority to MYPI2015002751A priority Critical patent/MY184269A/en
Priority to MYPI2018000817A priority patent/MY189021A/en
Priority to PCT/IB2016/057146 priority patent/WO2017090010A1/en
Priority to AU2016359545A priority patent/AU2016359545B2/en
Priority to JP2018526142A priority patent/JP2019506840A/ja
Priority to CN201680079962.8A priority patent/CN108699113A/zh
Priority to EP16868131.0A priority patent/EP3380493A4/en
Priority to US15/778,822 priority patent/US10538554B2/en
Publication of MY184269A publication Critical patent/MY184269A/en
Priority to JP2022029519A priority patent/JP2022088370A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI2015002751A 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides MY184269A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2018000817A MY189021A (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents
PCT/IB2016/057146 WO2017090010A1 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents
AU2016359545A AU2016359545B2 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents
JP2018526142A JP2019506840A (ja) 2015-11-27 2016-11-28 抗ウイルス剤としてのペプチドおよびこのための使用
CN201680079962.8A CN108699113A (zh) 2015-11-27 2016-11-28 肽及其作为抗病毒剂的用途
EP16868131.0A EP3380493A4 (en) 2015-11-27 2016-11-28 PEPTIDES AND USES THEREOF AS VIRUZIDES
US15/778,822 US10538554B2 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents
JP2022029519A JP2022088370A (ja) 2015-11-27 2022-02-28 抗ウイルス剤としてのペプチドおよびこのための使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides

Publications (1)

Publication Number Publication Date
MY184269A true MY184269A (en) 2021-03-30

Family

ID=58763140

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2018000817A MY189021A (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI2018000817A MY189021A (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Country Status (7)

Country Link
US (1) US10538554B2 (enExample)
EP (1) EP3380493A4 (enExample)
JP (2) JP2019506840A (enExample)
CN (1) CN108699113A (enExample)
AU (1) AU2016359545B2 (enExample)
MY (2) MY184269A (enExample)
WO (1) WO2017090010A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012894A (ko) * 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도
CN115244067A (zh) * 2019-08-29 2022-10-25 Ajk生物制药有限责任公司 合成抗微生物肽
CN111100194B (zh) * 2020-02-21 2022-03-25 佛山科学技术学院 一种抗菌肽pd-l4在抑制禽流感病毒中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4307841B2 (ja) * 2001-03-22 2009-08-05 アメリカ合衆国 グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
US7148404B2 (en) * 2004-05-04 2006-12-12 Novozymes A/S Antimicrobial polypeptides
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
CA2624153A1 (en) 2005-09-29 2007-04-12 The Scripps Research Institute Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
GB0718966D0 (en) * 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
CA2727898A1 (en) * 2008-06-13 2009-12-17 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus
GB201012651D0 (en) * 2010-07-28 2010-09-15 Univ Edinburgh Peptides
BR112014013853A2 (pt) * 2011-12-09 2020-01-14 Ceres Inc uso de um ácido nucleico isolado, método de obtenção de uma célula vegetal transgênica, método de obtenção de uma planta transgênica, método de produção de uma planta, método de produção de biomassa, método de processamento de biomassa, método de alteração da composição de biomassa, método de modulação de composição de biomassa, método de produção de um produto de forragem
EP3013425B1 (en) * 2013-06-27 2020-09-09 Rutgers, the State University of New Jersey Leukotoxin for use in the treatment of ocular disease
KR20200012894A (ko) * 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도

Also Published As

Publication number Publication date
US10538554B2 (en) 2020-01-21
EP3380493A4 (en) 2019-07-31
AU2016359545A1 (en) 2018-07-12
AU2016359545B2 (en) 2021-06-10
MY189021A (en) 2022-01-19
EP3380493A1 (en) 2018-10-03
US20180346516A1 (en) 2018-12-06
WO2017090010A1 (en) 2017-06-01
CN108699113A (zh) 2018-10-23
JP2022088370A (ja) 2022-06-14
JP2019506840A (ja) 2019-03-14

Similar Documents

Publication Publication Date Title
MX2021007679A (es) Anticuerpos humanos para hemaglutinina de influenza.
EP4233898A3 (en) Influenza mrna vaccines
CY1122792T1 (el) Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου δαγκειου ιου
MX387115B (es) Métodos para tratar la influenza.
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
MY201105A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
CA2991023C (en) Attenuated influenza vectors used for the prevention and/or treatment of infectious diseases as well as for the treatment of oncological diseases
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
PH12017500450A1 (en) Flavivirus virus like particle
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
BR112017005828A2 (pt) métodos para tratar ou prevenir uma infecção respiratória, copd e uma exacerbação de copd e para selecionar um inibidor de sinalização notch 3 e/ou notch4, usp de um inibidor de sinalização de notch 3 e/ou notch 4, inibidor de sinalização de notch 3 e/ou notch 4, e, composição farmacêutica.
MY184269A (en) Broad-spectrum anti-influenza virus therapeutic peptides
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
WO2014173859A3 (en) Par-4 antagonists for use in the treatment or prevention of influenza virus type a infections
MD4763B1 (ro) Compoziţie farmaceutică
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
EA201790771A1 (ru) Фармацевтические композиции длительного действия для лечения гепатита c
EA201790776A1 (ru) Комбинированные композиции длительного действия и способы лечения гепатита с
BR112017005993A2 (pt) derivados de peptídeo inovadores e usos dos mesmos
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
MX2019013874A (es) Peptidos y sus usos como agentes antivirales.
EP3582787A4 (en) PHARMACEUTICAL PREPARATION FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY AND DEGENERATIVE DISEASES
HK1238655A1 (en) Human antibodies to influenza hemagglutinin